418 related articles for article (PubMed ID: 32776022)
1. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.
Srivastava S; Verma S; Kamthania M; Kaur R; Badyal RK; Saxena AK; Shin HJ; Kolbe M; Pandey KC
JMIR Bioinform Biotech; 2020; 1(1):e19371. PubMed ID: 32776022
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach.
Srivastava S; Kamthania M; Singh S; Saxena AK; Sharma N
Infect Drug Resist; 2018; 11():2377-2391. PubMed ID: 30538505
[TBL] [Abstract][Full Text] [Related]
3. Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics.
Srivastava S; Kamthania M; Kumar Pandey R; Kumar Saxena A; Saxena V; Kumar Singh S; Kumar Sharma R; Sharma N
J Biomol Struct Dyn; 2019 Oct; 37(16):4345-4360. PubMed ID: 30457455
[TBL] [Abstract][Full Text] [Related]
4. Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health.
Srivastava S; Verma S; Kamthania M; Saxena AK; Pandey KC; Pande V; Kolbe M
PLoS One; 2023; 18(3):e0282580. PubMed ID: 36920996
[TBL] [Abstract][Full Text] [Related]
5. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
6. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide.
Srivastava S; Verma S; Kamthania M; Agarwal D; Saxena AK; Kolbe M; Singh S; Kotnis A; Rathi B; Nayar SA; Shin HJ; Vashisht K; Pandey KC
J Biomol Struct Dyn; 2022 Mar; 40(5):2369-2388. PubMed ID: 33155524
[TBL] [Abstract][Full Text] [Related]
7. Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
Khairkhah N; Aghasadeghi MR; Namvar A; Bolhassani A
PLoS One; 2020; 15(10):e0240577. PubMed ID: 33057358
[TBL] [Abstract][Full Text] [Related]
8. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
9. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
10. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
Dong R; Chu Z; Yu F; Zha Y
Front Immunol; 2020; 11():1784. PubMed ID: 32849643
[TBL] [Abstract][Full Text] [Related]
11. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
[TBL] [Abstract][Full Text] [Related]
12. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
13. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
Campos DMO; Silva MKD; Barbosa ED; Leow CY; Fulco UL; Oliveira JIN
Comput Biol Chem; 2022 Dec; 101():107754. PubMed ID: 36037724
[TBL] [Abstract][Full Text] [Related]
14. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
15. Exploring whole proteome to contrive multi-epitope-based vaccine for NeoCoV: An immunoinformtics and
Aziz S; Waqas M; Halim SA; Ali A; Iqbal A; Iqbal M; Khan A; Al-Harrasi A
Front Immunol; 2022; 13():956776. PubMed ID: 35990651
[TBL] [Abstract][Full Text] [Related]
16.
Devi A; Chaitanya NSN
J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
[TBL] [Abstract][Full Text] [Related]
17. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.
Chauhan V; Rungta T; Rawat M; Goyal K; Gupta Y; Singh MP
J Cell Physiol; 2021 Feb; 236(2):1131-1147. PubMed ID: 32643158
[TBL] [Abstract][Full Text] [Related]
18. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
[TBL] [Abstract][Full Text] [Related]
19. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
Samad A; Ahammad F; Nain Z; Alam R; Imon RR; Hasan M; Rahman MS
J Biomol Struct Dyn; 2022 Jan; 40(1):14-30. PubMed ID: 32677533
[TBL] [Abstract][Full Text] [Related]
20. Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis.
Jiang F; Liu Y; Xue Y; Cheng P; Wang J; Lian J; Gong W
Int Immunopharmacol; 2023 Feb; 115():109728. PubMed ID: 36652758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]